1Pettinato G, Manivel JC, De Rosa N, et al.Inflammatory myoflbroblastlc tumor (plasma cell granuloma). Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations [J]. Am J Clin Pathol, 1990,94(5) : 538-546.
2Coffin CM, Dehner LP, Meis-kindblom IM, et al. Inflammatory myofibro-blastic tumor, Inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations [J]. Semin Diagn Pathol, 1998,15(2) : 102-105.
3Coffin CM, Watterson J, Priest JR, et al. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor):a clinicopathologic and immunohistochemical study of 84 cases [J]. Am J Surg Pathol, 1995,19 (8) : 859-872.
4Fletcher CDM, Unni KK, Mertens F. WHO classification of tumors, pathology and genetic of tumors of soft tissue and bone [M]. Lyon, IARC Press,2002,91-93.
5Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor : comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive eases [J]. Am J Surg Pathol, 2007,31 (4) : 509-520.
6Sukov WR, Cheville JC, Carlson AW, et al. Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder [J]. Mod Pathol, 2007,20 (5) : 592-603.
7Coffin CM,Patel A,Perkins S,et al. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor [J]. Mod Pathol, 2001,14 (6) : 569-576.
8Hussong JW,Brown M, Perkins SL,et al. Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors [J]. Mod Pathol, 1999,12 (3) : 279-286.
9Biselli R, Boldrini R, Ferlini C, et al. Myofibroblastic tumours: neoplasias with divergent behaviour. Ultrastructural and flow cytometric analysis [J]. Pathol Res Pract,1999,195(9):619-632.
